Cytodyn Inc (CYDY)

[HighGrowth70]

It was a PII and the Trial size was simply too small. If the Trial (N) had been larger, it likely would have garnered more attention.

And... CYDY is not Big Pharma, with all their $$$, insider connections, and FDA track record...

That will change over time; once CYDY get's their first, second, et-all FDA approvals!

PS: Keep in mind; the small M/M Trial results have informed the Long Hauler Trial design - it has gotten attention. CYDY was correct to abandon the M/M work, focus cash on S/C completion, and prep for Long Haul trial. If/when they receive a S/C approval; that will naturally lead to M/M use via label expansion over time...

The long-game $$$ is in S/C and Long Haul treatments. Given that COVID is now an Endemic virus, there will be an insatiable demand (worldwide) for an effective treatment for both sides of the acute-virus and post-virus phase(s) - over the next many decade(s)...